Search
Search Results
- Author(s):
- Finegold, Kenneth, 1957- author
Sayed, Bisma A., author
- Publication:
- Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 16, 2022
- Subject(s):
- Costs and Cost Analysis
Drug Costs
Health Expenditures
Insulin -- economics
Diabetes Mellitus -- drug therapy
Diabetes Mellitus -- economics
Medication Adherence
United States
- Author(s):
- Purvis, Leigh, author
McSpadden, James, author
- Publication:
- Washington, DC : AARP Public Policy Institute, October 2022
- Subject(s):
- Biosimilar Pharmaceuticals
Cost Savings
Health Services Accessibility
Legislation, Drug
Drug Costs
State Government
United States
- Author(s):
- Hayford, Tamara, author
Austin, David, author
- Publication:
- [Washington, DC] : Congressional Budget Office, January 2022
- Subject(s):
- Drug Costs
Health Expenditures -- trends
Medicaid -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
United States
- Author(s):
- Cao, Shengmao, author
Chatterjee, Chirantan, author
- Publication:
- [Stanford, CA] : Stanford Institute for Economic Policy Research (SIEPR), January 6, 2022
- Subject(s):
- Drug Combinations
Drug Costs
Economic Competition
Economics, Pharmaceutical
India
United States
- Author(s):
- Cao, Shengmao, author
Yi, Lisa Xuejie, author
Yu, Chuan, author
- Publication:
- [Stanford, CA] : Stanford Institute for Economic Policy Research (SIEPR), January 2022
- Subject(s):
- Competitive Bidding
Drug Costs
Economics, Pharmaceutical
Models, Economic
China
United States
- Author(s):
- Whittington, Melanie D., author
Campbell, Jonathan D., author
Richardson, Marina, author
Nhan, Emily, author
McKenna, Avery, author
Agboola, Foluso, author
Pearson, Steven D., author
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, December 20, 2022
- Subject(s):
- Ambulatory Care -- economics
Antiviral Agents -- economics
COVID-19 Drug Treatment
Drug Combinations
Drug Costs
Lactams
Leucine
Nitriles
Proline
Ritonavir
United States
- Publication:
- Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
- Subject(s):
- Data Analysis
Drug Costs
Government Regulation
Medicare Part B
United States
- Publication:
- Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2022
- Subject(s):
- Cost Control
Drug Costs
Drug Industry
Government Regulation
Medicare Part B
Prescription Fees
United States
Centers for Medicare & Medicaid Services (U.S.)
- Publication:
- Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2022
- Subject(s):
- Drug Costs
Drug Industry
Government Regulation
Medicaid
Medicare Part B
Prescription Fees
United States
- Publication:
- Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, August 2023
- Subject(s):
- Cost Control
Drug Costs
Government Regulation
Medicare Part B
Prescription Fees
United States
